Hemangioblastoma of the cervical part of the spinal cord in the course of von Hippel-Lindau syndrome
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 1
Abstract
A 37-year-old patient was irradiated after a subtotal excision of the hemangioblastoma of the cervical spinal cord. On the basis of history, physical examination and performed additional tests, the diagnosis of VHL syndrome was established. The genetic examination revealed VHL gene mutation. Genetic tests were also performed in two children of the patient and did not reveal any mutations. The last one child was not examined. In 1998 the patient underwent coagulation because of hemangioblastoma recurrence in the right retina. In 2003 patient developed a progressive disease in the kidneys. The patient died in December 2003.
Authors and Affiliations
Krzysztof Małecki, Karol Krzystolik, Cezary Cybulski, Jan Lubiński, Stanisław Korzeniowski
Keywords
Related Articles
- EP ID EP112767
- DOI -
- Views 41
- Downloads 0
Brachyterapia PDR (pulsacyjna) w leczeniu raka piersi
Leczenie oszczędzające raka piersi w skojarzeniu z uzupełniającą radioterapią jest coraz powszechniej stosowaną metodą leczenia wczesnego niezaawansowanego raka piersi. W większości przypadków leczenie polega na napromie...
Superficial hyperthermia combined with hypofractionated radiotherapy of malignant melanoma metastases to skin and lymph nodes
Aim: The evaluation of combined radiohyperthermia in the treatment of skin and lymph nodes malignant melanoma metastases. Material and method: Material comprises 10 skin and 11 lymph nodes melanoma metastases (1...
Antygen raka płaskonabłonkowego (SCC) w diagnostyce i monitorowaniu leczenia chorych na raka szyjki macicy
Antygen raka płaskonabłonkowego (SCC – squamous cell carcinoma antigen) jest pierwszym markerem w raku szyjki macicy. SCC należy do rodziny inhibitorów proteaz serynowych. Podwyższone stężenie SCC występuje w rakach pł...
Central nervous system metastases in advanced breast cancer patients treated with trastuzumab
Amplification or overexpression of HER2 receptor is present in 20-30% of invasive breast cancers and in 60% of intraductal cancers. Patients with HER2 gene aberrations have more aggressive disease, frequent disease rec...
Leczenie operacyjne przerzutów do wątroby w przebiegu raka jelita grubego